Domov › Melanóm › Michigan

Klinické štúdie Melanóm v štáte Michigan

31 štúdií pre Melanóm hľadá účastníkov v zariadeniach v štáte Michigan.

Mestá v štáte Michigan

Oficiálny text štúdie (anglicky)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

South Texas Accelerated Research Therapeutics (START), Grand Rapids

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
a 68 ďalších

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
University of Michigan Rogel Cancer Center, Ann Arbor
Bronson Battle Creek, Battle Creek
a 23 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

University of Michigan, Ann Arbor
Henry Ford Cancer Institute/Henry Ford Health System, Detroit

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06246916

Pan-tumor MRD Study

The Cancer & Hematology Centers (CHC), Grand Rapids

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Bronson Battle Creek, Battle Creek
Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
a 8 ďalších

Prebieha náborFáza 3

Vek 75 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07068074

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

START Midwest, Grand Rapids

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT05267626

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0119, Ann Arbor

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

University of Michigan Comprehensive Cancer Center, Ann Arbor
Bronson Battle Creek, Battle Creek
University of Michigan - Brighton Center for Specialty Care, Brighton
a 15 ďalších

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Cancer & Hematology Centers of Western Michigan, Grand Rapids

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Wayne State University - Barbara Ann Karmanos Cancer Institute, Detroit

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07287917

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Brigitte Harris Cancer Pavilion BHCP, Detroit
START Midwest, LLC, Grand Rapids

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07070232

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

C S Mott Children's Hospital, Ann Arbor

Prebieha náborFáza 1/2

12 Months – 30 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

C S Mott Children's Hospital, Ann Arbor
Bronson Battle Creek, Battle Creek
Children's Hospital of Michigan, Detroit
a 14 ďalších

Prebieha náborObservačná štúdia

Do veku 25 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, Grand Rapids

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT07115043

A Study of MGC026 in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Karmanos Cancer Institute, Detroit

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT05592626

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

START Midwest, Grand Rapids

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 8. 2026 · NCT06880549

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Henry Ford Cancer Institute, Detroit

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 7. 2026 · NCT04198766

Neoadjuvant Darovasertib in Primary Uveal Melanoma

W Kellogg Eye Center, Ann Arbor
The Cancer and Hematology Centers of West Michigan (CHCWM), Grand Rapids

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 5. 2026 · NCT07015190

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Start Midwest Cancer Research, Grand Rapids

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 4. 2026 · NCT06413680

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
a 19 ďalších

Prebieha náborObservačná štúdia

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 3. 2026 · NCT06418204

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Research Site, Farmington Hills

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 3. 2026 · NCT06956690

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 129, Detroit

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 11. 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Ann Arbor
Massive Bio SYNERGY-AI site, Lansing

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

University of Michigan, Ann Arbor

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2025 · NCT05839912

A Beta-only IL-2 ImmunoTherapY Study

Karmanos Cancer Institute, Detroit

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 7. 2025 · NCT05086692

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Henry Ford Cancer Institute, Detroit

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 5. 2025 · NCT05970497

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center, Detroit

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 2. 2025 · NCT05669430

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Michigan Hematology & Oncology Consultants - MedOnc Dearborn, Dearborn
Michigan Hematology & Oncology Consultants - MedOnc Troy, Troy

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 12. 2024 · NCT06281678

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

University of Michigan Medical Center, Ann Arbor
University of Michigan - Brighton Center for Specialty Care, Brighton
Mercy Health Saint Mary's, Grand Rapids
a 2 ďalších

Prebieha nábor

Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 11. 2024 · NCT03860883

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.